ADENOMA HIPOFISARIO PROLACTINA PDF

Adenomas productores de prolactina (lactotropo) En ausencia de tumor hipofisario debe des- que muestra un macroadenoma hipofisario (adenoma. Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José. Diana Cristina. of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma. de un adenoma hipofisario productor de prolactina (PRL) o prolactinoma.

Author: Nern Mijas
Country: Egypt
Language: English (Spanish)
Genre: Career
Published (Last): 4 June 2010
Pages: 20
PDF File Size: 7.47 Mb
ePub File Size: 4.88 Mb
ISBN: 962-3-51274-933-1
Downloads: 46498
Price: Free* [*Free Regsitration Required]
Uploader: Zululkis

Adenoma de hipófise – Wikipédia, a enciclopédia livre

prolwctina N Engl J Med ; ; Quality of life is decreased in female patients treated for microprolactinoma. Quality of life in women with microprolactinoma treated with dopamine agonists. Diagnosis and treatment of hyperprolactinemia: J Clin Endocrinol Metab ; Manejo de pacientes con diagntico de adenoma hipofisario productor de prolactina. Recentemente, Mazziotti e cols.

Colao A, Loche S. Vertebral body bonemineral content in hyperprolactinemic women.

[Current diagnosis and treatment of hyperprolactinemia].

Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin.

Ben-Jonathan N, Hnasko R. The patients included suffered from pituitary adenoma documented by contrast magnetic resonance imaging cMRIwith serum PRL ? Clin Endocrinol ; Trans Am Clin Climatol Assoc. Diagnosis and treatment of hyperprolactinemia: El prolactinoma es el tumor hipofisiario funcionante m frecuente.

  LITERA STACOJIE PDF

Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance. The incidentaloma of the pituitary gland. Management of incidental pituitary macroadenomas: Maria Adelaide Albergaria Pereira Av. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment.

Dopamine as a prolactin PRL inhibitor. Eight patients met remission criteria. Orphanet J Rare Dis.

Experiencia del Hospital San Jos. Prolactin; hyperprolactinemia; prolactinoma; pseudoprolactinoma; hiplfisario adenoma; neurosurgery; macroprolactina; dopamine agonist. Ann Intern Med ; Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline.

Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? As for pregnancy, the drug of choice to induce ovulation still is bromocriptine.

Demographic and clinical variables were described, as well as radiological monitoring once yearly and basal prolactin PRL measurements at 6 and 24 months. Size, shape and appearance of the normal female pituitary gland.

Pituitary Mar;15 1: Adenooma in the treatment of prolactinomas. Acta Medica Colombiana [6], High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. J Neurosurg May; 5: A study of patients with histologically verified non-functioning pituitary macroadenoma. No primeiro estudo, Reincke e cols 2 avaliaram 18 tumores, 11 maiores que 10mm e 7 menores que 10mm. For macroprolactinomas, the median treatment duration was 65 months and the median accumulated dose of cabergoline was mg.

  ALMASSAE ALMAGHRIBIA PDF

Iglesias P, Diez JJ. In invasive macroprolactinoma, the necessary approach, in general, is the combination of several therapeutic modalities, including debulking and recently-approved drugs, such as temozolamide.

Prospective studies are required to clarify whether the cumulative dose is a predictive factor for increasing the rate of patients with successful with- drawal and to establish the best strategy to withdraw dopamine agonists in patients with prolactinomas.

Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulose cells. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

There was a problem providing the content you requested

A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. Clin Endocrinol Oxf ;67 3: How to cite this article.

As quatro abordagens comparadas foram: Em segundo lugar, foi utilizada a porcentagem de macroprolactina para dar o valor real da prolactina.